SOPHiA GENETICS expands partnership with AstraZeneca to include multimodal approaches for cancer drug development
SOPHiA GENETICS, a data-driven medicine software company, told investors it is partnering with AstraZeneca PLC (LSE:AZN) to apply its multimodal technology...